Sep 9, 2024 · The primary objective of this trial was to assess the safety and tolerability of allogeneic NK cells in children with relapsed/refractory neuroblastomas ...

Sep 24, 2024 · In this context, the allogeneic HSCT setting provides an alternative source for safe and efficient adoptive allogeneic CIK cell strategies against a variety of ...

Sep 20, 2024 · Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after anti–PD-1/PD-L1 treatments. Transplant- related ...

Sep 9, 2024 · Fatal and other serious complications can occur in patients who receive allogeneic hematopoietic stem cell transplantation (HSCT) before or after being treated ...

Sep 14, 2024 · Immune checkpoint inhibitors (ICI) have become the cornerstone of treatment in renal cell carcinoma (RCC), for both metastatic disease and in an adjuvant ...

Sep 23, 2024 · Our findings demonstrate that even early post-HCT, T cells retard donor HSC engraftment and immune recovery.

Sep 14, 2024 · KEYTRUDA is approved as a monotherapy for the treatment of patients with HCC secondary to hepatitis B who have received prior systemic therapy other than a PD-1 ...

Sep 15, 2024 · Fatal and other serious complications can occur in patients who receive allogeneic hematopoietic stem cell transplantation (HSCT) before or after being treated ...

Sep 15, 2024 · Complications of Allogeneic HSCT after IMFINZI Fatal and other serious complications can occur in patients who receive allogeneic hematopoietic stem cell ...